...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Re: Future Trials
5
Feb 14, 2020 02:12AM
2
Feb 14, 2020 09:18AM
2
Feb 14, 2020 09:39AM

BDZ,

Those are the rules and you explain them very well and clearly,... But as we see, the FDA is softening a bit.

If you took any ordinary person and showed them the results we had with Stroke where we just failed,... and then you show him the results of CHF where we passed with extreme colors,.. without and other info like Primary or Secondary endpoints etc,...

Each and every person would say: ALLOW the drug to be available to the public.

What us lay peolple don't understand is the rules that have been implimented to NOT allow great results to be made available because of the LABEL,.. SECONDARY ENDPOINT.

 

 

 

3
Feb 14, 2020 10:07AM
2
Feb 14, 2020 11:20AM
2
Feb 14, 2020 01:36PM
7
Feb 14, 2020 02:40PM
8
Feb 14, 2020 02:45PM
2
Feb 14, 2020 03:32PM
Share
New Message
Please login to post a reply